Abstract
Natural alkaloid galantamine is widely used for the treatment of Alzheimer’s disease and various other memory impairments. Galantamine hydrobromide (GH) is available as fast-release tablets, extended-release capsules, and oral solution. However, oral delivery of GH can cause side effects, such as nausea, vomiting, and gastrointestinal disturbance. Transdermal delivery is one possible way to avoid such unwanted effects and is also patient friendly, especially for unconscious patients, patients with swallowing difficulties, and patients with mental disturbances. In this work, thermoresponsive copolymer networks based on poly(N-isopropylacrylamide) were studied as new platforms for potential transdermal GH delivery. Series of networks of varied structure and composition were synthesized and investigated by applying swelling kinetics and different spectroscopic and thermal methods. The network films were drug loaded in GH aqueous solution and main characteristics of the obtained GH delivery systems were evaluated. The GH release kinetic profiles in BS at 37 °C were established and discussed.
Similar content being viewed by others
References
Giau VV, An SS, Bagyinszky E, Kim SY (2015) Next generation sequencing (NGS) gene panels and primers for studies on neurodegenerative disorders. Toxicol Environ Heal Sci 7:S32
Lyseng-Williamson KA, Plosker GL (2003) Spotlight on galantamine in Alzheimer’s disease. Disease Manag Health Outcome 11(2):125–128
Robinson DM, Plosker GL (2006) Galantamine extended release. CNS Drugs 20(8):673–681
Maltz MS, Kirschenbaum HL (2002) Galantamine: a new acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease. P&T 27(3):135–138
Drug label: REMINYL® (Galantamine HBr), (2001) tablets and oral solution, Food and Drug Administration
Aleksiev A, Kostova B, Rachev D (2016) Development and optimization of the reservoir-type oral multiparticulate drug delivery systems of galantamine hydrobromide. Indian J Pharm Sci 78(3):368–376
Biswal B, Sharma D (2013) Design, development and evaluation of galantamine hydrobromide bilayer sustained release tablet. Pharm Lett 5(6):12–19
Aleksiev A, Kostova B, Rachev D (2014) Development of Eudragit based sustained release systems of galantamine hydrobromide. Int J Pharm Sci Rev Res 27(1):135–140
Inglis F (2002) The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int J Clin Pract Suppl 127:45–63
Small G, Dubois B (2007) A review of compliance to treatment in Alzheimer’s disease: potential benefits of a transdermal patch. Curr Med Res Opin 23(11):2705–2713
Misra S, Chopra K, Sinha VR, Medhi B (2016) Galantamine-loaded solid–lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations. Drug Deliv 23(4):1434–1443
Fornaguera C, Feiner-Gracia N, Caldero G, Garcia-Celma MJ, Solans C (2015) Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases. Nanoscale 7:12076–12084
Hanafy AS, Farid RM, El Gamal SS (2015) Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer’s disease management: preparation and detection in rat brain. Drug Dev Ind Pharm 41:2055–2068
Utsuki T, Uchimura N, Irikura M, Moriuchi H, Holloway HW, Yu QS, Spangler EL, Mamczarz J, Ingram DK, Irie T, Greig NH (2007) Preclinical investigation of the topical administration of phenserine: transdermal flux, cholinesterase inhibition, and cognitive efficacy. J Pharmacol Exp Ther 321(1):353–361
Woo FY, Mahiran B, Mansor A, Maznah I (2015) Formulation and evaluation of galantamine gel as drug reservoir in transdermal patch delivery system. Sci World J 2015:495271
Koetting MC, Peters JT, Steichen SD, Peppas NA (2015) Stimulus-responsive hydrogels: theory, modern advances, and applications. Mater Sci Eng R 93:1–49
Hoffman AS (2013) Stimuli-responsive polymers: biomedical applications and challenges for clinical translation. Adv Drug Deliv Rev 65(1):10–16
Yang J, Shen D, Zhou L, Li W, Li X, Yao C, Wang R, El-Toni AM, Zhang F, Zhao D (2013) Spatially confined fabrication of core-shell gold nanocages@mesoporous silica for near-infrared controlled photothermal drug release. Chem Mater 25:3030–3037
Cui H, Liu Y, Cheng Y, Zhang Z, Zhang P, Chen X, Wei Y (2014) In vitro study of electroactive tetra aniline containing thermosensitive hydrogels for cardiac tissue engineering. Biomacromolecules 15:1115–1123
Li L, Yan B, Yang J, Chen L, Zeng H (2015) Novel mussel-inspired injectable self-healing hydrogel with anti-biofouling property. Adv Mater 27:1294–1299
Hoare TR, Kohane DS (2008) Hydrogels in drug delivery: progress and challenges. Polymer 49:1993–2007
Calo E, Khutoryanskiy V (2015) Biomedical applications of hydrogels: a review of patents and commercial products. Eur Polym J 65:252–267
Li J, Mooney DJ (2016) Designing hydrogels for controlled drug delivery. Nat Rev Mater 1(12):1607–1611
Zhuang J, Gordon MR, Ventura J, Li L, Thayumanavan S (2013) Multi-stimuli responsive macromolecules and their assemblies. Chem Soc Rev 42:7421–7435
Lima LH, Morales Y, Cabral T (2016) Ocular biocompatibility of poly-N-isopropylacrylamide (pNIPAM). J Ophthalmol 2016:5356371
Ohya S, Nakayama Y, Matsuda T (2004) In vivo evaluation of poly(N-isopropylacrylamide) (PNIPAM)-grafted gelatin as an in situ-formable scaffold. J Artif Organs 7:181–186
Cho JH, Kim SH, Park KD, Jung MC, Yang WI, Han SW, Noh JY, Lee JW (2004) Chondrogenic differentiation of human mesenchymal stem cells using a thermosensitive poly(N-isopropylacrylamide) and water-soluble chitosan copolymer. Biomaterials 2:5743–5751
Cao Y, Zhang C, Shen W, Cheng Z, Yu L, Ping Q (2007) Poly(N-isopropylacrylamide)–chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J Control Release 120:186–194
Li W, Deng L, Moosa B, Wang G, Mashat A, Khashab NM (2014) “Nail” and “comb” effects of cholesterol modified NIPAm oligomers on cancer targeting liposomes. Biomater Sci 4:476–483
Zhu X, Yan C, Winnik FM, Leckband D (2007) End-grafted low-molecular-weight PNIPAM does not collapse above the LCST. Langmuir 23:162–169
Hoshino Y, Nakamoto M, Miura YJ (2012) Control of protein binding kinetics on synthetic polymer nanoparticles by tuning flexibility and inducing conformation changes of polymer chains. J Am Chem Soc 134:15209–15212
Lanzalaco S, Armelin E (2017) Poly(N-isopropylacrylamide) and copolymers: a review on recent progresses in biomedical applications. Gels 3:36
Satarkar NS, Hilt JZ (2008) Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release. J Control Release 130:246–251
Purushotham S, Chang PEJ, Rumpel H, Kee IHC, Ng RTH, Chow PKH, Tan CK, Ramanujan RV (2009) Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy. Nanotechnology 20(30):305101
Qiu Y, Park K (2012) Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 64:49–60
Huang G, Gao J, Hu Z, John JVS, Ponder BC, Moro D (2004) Controlled drug release from hydrogel nanoparticle networks. J Control Release 94:303–311
Zhang XZh WDQ, Chu CC (2004) Synthesis, characterization and controlled drug release of thermosensitive IPN–PNIPAAm hydrogels. Biomaterials 25:3793–3805
Georgieva D, Kostova B, Ivanova S, Rachev D, Tzankova V, Kondeva-Burdina M, Christova D (2014) pH-sensitive cationic copolymers of different macromolecular architecture as potential dexamethasone sodium phosphate delivery systems. J Pharm Sci 103:2406–2413
Acknowledgments
The authors acknowledge Dr. Philip Ublekov for the XRD measurements and helpful discussion.
Funding
Part of this work is supported by the Bulgarian Ministry of Education and Science under the National Research Programme BioActiveMed: “Innovative Low-Toxic Bioactive Systems for Precision Medicine” (Grant D01-217/30.11.2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Georgieva, D., Ivanova-Mileva, K., Ivanova, S. et al. Thermoresponsive poly(N-isopropylacrylamide) copolymer networks for galantamine hydrobromide delivery. Colloid Polym Sci 298, 377–384 (2020). https://doi.org/10.1007/s00396-020-04621-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00396-020-04621-8